What is the revenue and EPS growth rate for Amn Healthcare Services year over year?

What were the key takeaways from Amn Healthcare Services's earnings call?

What were the key takeaways from Amn Healthcare Services’s earnings call?

What guidance did Amn Healthcare Services's management provide for the next earnings period?

What is Amn Healthcare Services's gross profit margin?

What is Amn Healthcare Services's latest dividend and current dividend yield?

Did Amn Healthcare Services beat or miss consensus estimates last quarter?

What is the market's earnings forecast for Amn Healthcare Services next quarter?

- **Revenue Beat**: Q3 revenue of $634 million (+8% YoY) exceeded guidance, driven by Nurse and Allied Solutions (+$12 million). Adjusted EBITDA margin of 9.1% was 20bps above guidance.
- **Gross Margin Volatility**: Q3 gross margin 29.1% (24.1% in Nurse and Allied), with Labor Disruption revenue boosting margins. Q4 gross margin expected to decline 100bps YoY due to mix and seasonality.
- **Strategic Growth**: 20%+ growth in international Nurse placements and VMS recovery in 2026. Travel Nurse bill rates set to rise modestly in Q4 for the first time in 3 years.
- **Financial Strength**: $53 million cash, $850 million debt (3.3x net leverage). Q4 guidance includes $100 million Labor Disruption revenue, with 2026 focus on margin recovery through contingent workforce solutions.

**【CEO Summary Section】**
- **Revenue Performance**: Q3 revenue of $634 million exceeded guidance, driven by Nurse and Allied Solutions (+$12 million) and strong demand in Travel Nurse and winter orders. Adjusted EBITDA was $57.5 million, 9.1% of revenue, above the high end of guidance.
- **Gross Margin Dynamics**: Consolidated gross margin was 29.1%, with Nurse and Allied segment gross margin at 24.1% (down 90bps YoY). Labor Disruption revenue contributed 150bps to Q3 gross margin but is expected to drag Q4 margins by 100bps.
- **Strategic Initiatives**: Investment in AI and technology (e.g., PreCheck predictive analytics) to improve clinician engagement and fill rates. International Nurse placements are expected to grow 20%+ in 2026, supporting margin recovery.
- **Demand Trends**: Travel Nurse demand rebounded 50% from mid-May lows, with modest year-over-year growth in winter orders. Permanent hiring activity fell, driving interest in contingent workforce solutions.

**【CFO Financial Commentary】**
- **Financial Highlights**: GAAP net income of $29 million, adjusted EPS of $0.39 (vs. $0.61 YoY). Operating cash flow of $23 million, with $53 million in cash and $850 million in debt (net leverage 3.3x).
- **Q4 Guidance**: Revenue $715-$730 million, gross margin 25.5%-26.0%, SG&A 20.0%-20.5% of revenue. Excluding Labor Disruption, gross margin would be ~26.5%.
- **Cost Management**: Sequential SG&A decline of $11 million (to $139 million) due to lower bad debt and reserve adjustments. Capital expenditures remain disciplined, with $8 million in Q3.

**【Q&A Key Highlights】**
- **Gross Margin Outlook**: Q4 gross margin expected to decline 100bps YoY due to Labor Disruption mix and seasonality. 2026 margin recovery driven by international placements, VMS growth, and bill rate normalization.
- **Demand Drivers**: Travel Nurse volume growth (+50% from mid-May lows), Locum Tenens MSP wins (+15% YoY), and schools business momentum. Language Services and VMS face pricing pressure but are expected to stabilize.
- **Competitive Landscape**: Clients increasingly prioritize total talent solutions platforms. Bill rates for Nurse and Allied Solutions expected to rise modestly in Q4 for the first time in 3 years.
- **Risk Management**: Debt refinanced to extend maturity to 2029, reducing carrying costs. Days sales outstanding improved to 57 days, reflecting strong collections.


AMN Healthcare Services, Inc. (AMN) Q3 2025 Earnings Call Transcript

Revenue

Sales and Services Revenue

Financing Services Revenue

Other Revenue

Cost of Revenue

Cost of Goods and Services

Cost of Financing Services

Other Cost

Gross Profit

Other Operating Income

Operating Expenses

Selling, General and Administrative Expenses

Selling and Marketing Expenses

General and Administrative Expenses

Research and Development Expenses

Loss on Bad Debts

Loss on Impairment of Other Assets

Loss on Disposal of Assets

Other Operating Expenses

Operating Income

Non-Operating Income (Loss)

Income (Loss) from Affiliates

Income (Loss) from Associates

Income (Loss) from Joint ventures

Gain (Loss) on Other Investment

Gain (Loss) on Change in Fair Value

Gain (Loss) on Foreign Currency Exchange

Other Non-Operating Income (Loss)

Net Interest Expense

Interest Expense

Interest Income

Pretax Income From Continuing Operations

Income Tax Expense

Current Income Tax

Deferred Income Tax

Income Tax Adjustments

Net Income from Continuing Operations

Income from Discontinued Operations

Other Items Before Net Income

Net Income

Net Income Attributable to Minority Interests

Net Income Attributable to Owners of the Company

Preferred Stock Dividends

Other Adjustments

Net Income Attributable to Common Stockholders

Other Comprehensive Income

Total Comprehensive Income

Total Comprehensive Income Attributable to Minority Interests

Total Comprehensive Income Attributable to Owners of the Company

Basic EPS

Basic EPS from Continuing Operations

Basic EPS from Discontinued Operations

Diluted EPS

Diluted EPS from Continuing Operations

Diluted EPS from Discontinued Operations

AMN

AMN fundamentals

You can ask Aime